You are here

  • Home
  • Archive
  • Volume 94, Issue 10
  • Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

Article metrics

Article menu
Download PDFPDF
Multiple sclerosis
Original research
Association of age and inflammatory disease activity in the pivotal natalizumab clinical trials in relapsing-remitting multiple sclerosis

 

Online download statistics by month:

Online download statistics by month: May 2023 to September 2024

AbstractFullPdf
May 202314839252
Jun 20237735314
Jul 2023670147
Aug 20236662012
Sep 202315657036
Oct 20234384431
Nov 202311022518
Dec 20232471811
Jan 2024154177
Feb 20245743
Mar 20248853
Apr 202411333
May 202411532
Jun 202417165
Jul 20247947
Aug 20245133
Sep 20248233
Total7854384217